Biocon Biologics gets Japenese nod for Psoriasis Vulgaris injection Ustekinumab BS Ruchika Sharma7 Jan 2025 1:15 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the...
Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, Japan Ruchika Sharma29 Aug 2024 12:30 PM ISTBangalore: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced today that the...
Biocon Biologics secures US market entry date for Bmab 1200, a Proposed Biosimilar to Stelara Ruchika Sharma1 March 2024 3:30 PM ISTStelara (Ustekinumab) is a monoclonal antibody medication that prevents abnormal regulation of interleukin IL-12/23 associated immune diseases and has...
Lupin bags tentative USFDA nod for generic equivalent of Janssen Biotech Erleada Tablets Ruchika Sharma14 Oct 2023 1:00 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Natco Pharma seeks USFDA nod for generic Erdafitinib Tablets Ruchika Sharma27 July 2023 11:41 AM ISTHyderabad: NATCO Pharma Limited has announced the submission of Abbreviated New Drug Application (ANDA) containing a paragraph IV certification...
Intas Pharma marketing authorization application for proposed biosimilar of Stelara accepted by EMA Ruchika Sharma15 July 2023 11:00 AM ISTDMB-3115 is a proposed biosimilar to Stelara which is a blockbuster drug developed by Janssen Biotech Inc. for plaque psoriasis, psoriatic arthritis,...
Janssen Biotech, Cellular Biomedicine Group collaborate to develop next generation CAR-T therapies Ruchika Sharma4 May 2023 3:30 PM ISTUnder terms of the agreement, CBMG will grant Janssen a worldwide license to develop and commercialize the CAR-T assets, except in Greater China.
Glenmark Pharma bags USFDA nod for prostate cancer drug Abiraterone Acetate Ruchika Sharma20 May 2022 12:15 PM ISTProstate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate.
FDA approves Empliciti to treat multiple myeloma Meghna A Singhania3 Dec 2015 12:35 PM ISTToday the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with...
